h.ferrari
TL2 Moderator · Kuopio
Contributes reviews on supplier material. Based in Kuopio.
Joined 17 November 2024 · last posted 2d
82 posts, newest first. Showing up to 150.
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #76 · Outcomes › Body composition · 26 Jul 2026 · 20 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #43 · Sourcing › Regulatory · 19 Jul 2026 · 0 likes On post #39 — agreed on the reasoning, with one qualification. Off-label use and medical practice: clinicians can prescribe approved medications off-label under some…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #77 · Outcomes › Progress reports · 18 Jul 2026 · 0 likes This follows post #74 rather than contradicting it. Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them…
-
Alcohol: what is documented and what is folklore Replied, post #117 · Practice › Interactions · 17 Jul 2026 · 21 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #65 · Evidence › Journal club · 15 Jul 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Athletes in weight-category sports: a different risk calculus Replied, post #22 · Clinical › Special populations · 12 Jul 2026 · 11 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #92 · Data & Tools › Datasets · 7 Jul 2026 · 8 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Research-use-only status: what it means legally and practically Replied, post #65 · Compounds › Other compounds · 27 Jun 2026 · 4 likes Worth separating two things that post #61 runs together. Research-use-only status is a legal classification, not a safety classification. It means the compound is sold…
-
Follow-up: Signs of dehydration worth acting on Started this topic · Safety › Adverse events · 18 Jun 2026 · 30 likes Posting this under the heading it deserves: Signs of dehydration worth acting on Everything below is what sits behind that. General question, not a request for advice…
-
Tracking a shortage from primary sources rather than rumour Replied, post #55 · Access › Shortages · 17 Jun 2026 · 0 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #78 · Practice › Storage & stability · 7 Jun 2026 · 10 likes This follows post #75 rather than contradicting it. Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure…
-
Reading a home test result without over-claiming Replied, post #40 · Analytics › Home & field testing · 12 May 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #21 · Compounds › Semaglutide · 11 May 2026 · 5 likes Coming back to post #19, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #44 · Evidence › Preprints · 3 May 2026 · 0 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
-
Step therapy requirements and how to satisfy them Replied, post #6 · Access › Insurance & coverage · 25 Apr 2026 · 30 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #79 · Sourcing › Regulatory · 18 Apr 2026 · 8 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #82 · Clinical › Bloodwork · 17 Apr 2026 · 0 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #90 · Analytics › Mass spectrometry · 31 Mar 2026 · 27 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #112 · Research Methods › N-of-1 designs · 28 Mar 2026 · 5 likes Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a week-long half-life, roughly a month is needed to…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #42 · Evidence › Trials · 24 Mar 2026 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #15 · Evidence › Journal club · 24 Mar 2026 · 26 likes post #14 is right about the mechanism and I think understates the practical bit. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #63 · Clinical › Bloodwork · 12 Mar 2026 · 3 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
Designing a personal experiment that could change your mind — one year on Replied, post #19 · Research Methods › N-of-1 designs · 10 Mar 2026 · 8 likes This follows post #16 rather than contradicting it. Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined number of…
-
A calculator that gives a right answer to the wrong question Replied, post #8 · Data & Tools › Calculators · 4 Mar 2026 · 1 like Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors that come from forgetting units. Always verify units in and out.
-
The lowest dose that does anything: is that a real question? Replied, post #35 · Practice › Dosing & titration · 3 Mar 2026 · 18 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Five questions in one post gets you one answer — how to split them Replied, post #19 · Start Here › How to Ask · 25 Feb 2026 · 0 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #78 · Analytics › Impurities & related substances · 20 Feb 2026 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #2 · Sourcing › Independent verification · 26 Jan 2026 · 18 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
Trifluoroacetate content and its consequences Replied, post #4 · Analytics › Impurities & related substances · 21 Jan 2026 · 0 likes Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common in storage, especially if the solution is exposed to light or if…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #51 · Sourcing › Red flags · 15 Jan 2026 · 5 likes Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
-
A parcel stationary at a customs facility for nine days Replied, post #16 · Sourcing › Logistics · 31 Dec 2025 · 31 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
-
Documentation that appears only after payment Replied, post #103 · Sourcing › Red flags · 11 Dec 2025 · 0 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
Tracking a preprint to publication: a worked example Replied, post #22 · Evidence › Preprints · 1 Dec 2025 · 0 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #110 · Practice › Reconstitution · 1 Dec 2025 · 13 likes This follows post #107 rather than contradicting it. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #65 · Compounds › Oral incretins · 28 Nov 2025 · 2 likes On post #61 — agreed on the reasoning, with one qualification. Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of…
-
Substitution between formats during a shortage Replied, post #100 · Access › Shortages · 21 Nov 2025 · 0 likes Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful.
-
Search filters: what is missing Replied, post #4 · Meta › Site feedback · 19 Nov 2025 · 3 likes the opening post answers the question as asked. The question underneath it is different. Moderation decisions: if you disagree with a moderation decision, raising it…
-
Second pass at: Programming during a large energy deficit Replied, post #85 · Nutrition & Training › Resistance training · 17 Nov 2025 · 8 likes Cardio and resistance: the interaction between energy-intense cardiovascular training and resistance training is real. Moderate cardio is fine; excessive endurance…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #7 · Practice › Interactions · 17 Nov 2025 · 0 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
EMA product information as a primary source Replied, post #50 · Regional › European Union · 10 Nov 2025 · 4 likes Cross-border purchase rules: buying a prescription in one EU country and bringing it home is complex. The substance is legal but crossing borders with it requires…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #15 · Compounds › Tirzepatide · 7 Nov 2025 · 1 like The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
-
Cross-border purchase rules within the EU Replied, post #28 · Regional › European Union · 23 Oct 2025 · 2 likes I read post #26 twice before replying, because I had assumed the opposite. Spain: AEMPS is the regulator. Public reimbursement for weight management has been limited…
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #19 · Data & Tools › Calculators · 17 Oct 2025 · 12 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #78 · Evidence › Journal club · 13 Oct 2025 · 19 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Documentation that appears only after payment Replied, post #45 · Sourcing › Red flags · 10 Oct 2025 · 1 like Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
-
How to read a forest plot, properly, from scratch Replied, post #36 · Evidence › Trials · 4 Oct 2025 · 15 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
-
Managing an unplanned gap in supply — what changed since Replied, post #75 · Access › Shortages · 30 Sep 2025 · 10 likes Coming back to post #73, because the follow-up matters more than the original answer. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose…
-
Thyroid function tests during substantial weight change Replied, post #61 · Clinical › Bloodwork · 14 Sep 2025 · 24 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #9 · Meta › Announcements · 1 Sep 2025 · 0 likes Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if you want to stay current.
-
Comparing two chromatograms from different laboratories, properly Replied, post #7 · Analytics › HPLC & UHPLC · 31 Aug 2025 · 3 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #89 · Compounds › Cagrilintide & amylin analogues · 26 Aug 2025 · 17 likes post #88 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
What a 2 ppm match establishes, and what it does not Replied, post #44 · Analytics › Mass spectrometry · 22 Aug 2025 · 0 likes Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈ 1371, quadruply at ≈ 1029. Those are the positions…
-
Travel coolers and how long they really hold Replied, post #38 · Devices › Cold chain · 3 Aug 2025 · 7 likes post #37 is right about the mechanism and I think understates the practical bit. Shipping container and cold packs: reputable suppliers use insulated containers with…
-
A comparison of home results against a laboratory result on the same vial Replied, post #20 · Analytics › Home & field testing · 1 Aug 2025 · 12 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
-
A field-by-field walk through a certificate of analysis Replied, post #124 · Analytics › COA interpretation · 18 Jul 2025 · 4 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #131 · Compounds › Cagrilintide & amylin analogues · 10 Jun 2025 · 11 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #21 · Clinical › Special populations · 9 Jun 2025 · 5 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reading a supplier's product description as a marketing document Replied, post #22 · Compounds › Other compounds · 14 May 2025 · 14 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Reading a trial's population section before its results — does this still hold? Replied, post #59 · Evidence › Trials · 2 May 2025 · 1 like Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
Over-dilution: when your dose falls below one readable graduation Replied, post #18 · Practice › Reconstitution · 30 Mar 2025 · 9 likes Picking up post #15: that is the part I would want checked first. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on…
-
Asking about a compound your prescriber has not heard of Replied, post #7 · Clinical › Prescriber conversations · 29 Mar 2025 · 9 likes Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final dose), discussing that explicitly and…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Started this topic · Analytics › Mass spectrometry · 28 Mar 2025 · 36 likes Oxidation and deamidation mass shifts, tabulated — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #24 · Practice › Interactions · 24 Mar 2025 · 9 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #32 · Evidence › Journal club · 9 Mar 2025 · 0 likes post #31 answers the question as asked. The question underneath it is different. Session format: read the paper before posting. The discussion is much better when…
-
What to keep a record of at the point of payment Started this topic · Sourcing › Payments · 8 Mar 2025 · 46 likes What to keep a record of at the point of payment — that is the question, and I have not found it answered plainly anywhere I have looked. Structured report rather than…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #102 · Compounds › Semaglutide · 8 Feb 2025 · 5 likes post #101 answers the question as asked. The question underneath it is different. The STEP programme populations were selected: enrollment criteria required baseline…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #11 · Compounds › Tirzepatide · 27 Jan 2025 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #39 · Analytics › COA interpretation · 22 Jan 2025 · 8 likes post #38 answers the question as asked. The question underneath it is different. What fields matter on a certificate: lot number matching the vial, test date, the…
-
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #19 · Devices › Syringes & needles · 14 Jan 2025 · 1 like Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #77 · Compounds › Tirzepatide · 8 Dec 2024 · 29 likes post #76 answers the question as asked. The question underneath it is different. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the…
-
Washout with a one-week half-life: the arithmetic Replied, post #15 · Research Methods › N-of-1 designs · 25 Nov 2024 · 22 likes Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #137 · Compounds › Other compounds · 23 Nov 2024 · 1 like How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
Two sessions a week versus four: what the evidence supports Replied, post #8 · Nutrition & Training › Resistance training · 19 Nov 2024 · 4 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Converting between mg/mL and units per dose, both directions Replied, post #90 · Practice › Reconstitution · 15 Nov 2024 · 26 likes Worth separating two things that post #86 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
US compounding rules and how they changed Replied, post #50 · Regional › North America · 31 Oct 2024 · 13 likes Indigenous healthcare systems: different indigenous healthcare systems have different medication access. Pathways through tribal health systems differ from mainstream…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #10 · Compounds › Other compounds · 28 Oct 2024 · 0 likes Picking up post #7: that is the part I would want checked first. Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #73 · Evidence › Journal club · 14 Oct 2024 · 7 likes On post #69 — agreed on the reasoning, with one qualification. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #9 · Sourcing › Regulatory · 9 Oct 2024 · 3 likes post #8 answers the question as asked. The question underneath it is different. Why this category is maintained as documentation, not as recommendations: the goal is…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #56 · Nutrition & Training › Hydration & electrolytes · 24 Aug 2024 · 0 likes Worth separating two things that post #52 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #22 · Analytics › Mass spectrometry · 14 Aug 2024 · 1 like post #21 answers the question as asked. The question underneath it is different. Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #120 · Compounds › Retatrutide · 24 Jul 2024 · 3 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #136 · Practice › Dosing & titration · 10 Jul 2024 · 17 likes On post #132 — agreed on the reasoning, with one qualification. Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The…